Areté
← All peptides
Lipotropic vitamin/amino blend (fat loss)community

Lipo-C

Lipo-C (lipotropic MIC injection)

The “fat-burning shot” you see on the menu at weight-loss clinics — and the one entry here that isn’t a peptide at all. Lipo-C is a mixed bag of B-vitamins and amino acids (the classic MIC trio plus extras) sold on the promise that injecting the molecules your liver uses to process fat will make you burn more of it. The honest headline is the one the menu leaves off: there is essentially no good human evidence that the shot itself does anything for weight.

Type
Lipotropic
Area
Vitamins & cofactors
Class
Lipotropic vitamin/amino blend (fat loss)
Standard dose
~1 mL of a MIC + B12 blend, IM or SubQ, weekly to twice weekly
Evidence
community

What it is

People get it for fat loss — usually as a weekly or twice-weekly injection bundled into a clinic’s diet-and-coaching program, often alongside a GLP-1 or a calorie-restricted plan. What it actually contains is a blend, not a drug: most commonly methionine, inositol, and choline (the “MIC” base), almost always with vitamin B12, and sometimes L-carnitine or other B-vitamins. Said plainly up front: any weight change people see on Lipo-C tracks the diet and program it’s sold alongside, not the injection. The shot is the ritual; the deficit is the mechanism.

The pitch is built on a real and genuinely elegant biochemistry, which is what makes it persuasive. These really are “lipotropic” molecules — choline and methionine are bona fide players in how the liver packages and exports fat, inositol sits in lipid-signaling pathways, and B12 is a true cofactor in energy metabolism. The leap the marketing makes is from “these molecules are involved in fat metabolism” to “injecting them will strip fat off you,” and that leap has never landed in humans. It’s a textbook case of a correct mechanism story standing in for a results story that isn’t there.

Mechanism

“Lipotropic” literally means fat-loving — historically the term for nutrients that help move fat out of the liver. Choline is a building block of phosphatidylcholine, which the liver needs to assemble VLDL particles and export triglycerides; methionine donates methyl groups (via SAMe) for that and for homocysteine handling; inositol contributes to lipid signaling; B12 and the other B-vitamins are cofactors in one-carbon and energy metabolism. All of that is real cell biology. What does not follow is a whole-body fat-loss effect: correcting or topping up these nutrients in someone who isn’t deficient doesn’t create an energy deficit, and energy deficit is what actually moves the scale. The mechanism is genuine; its relevance to fat loss in a fed, non-deficient person is the unsupported part.

Standard dose

Standard dose~1 mL of a MIC + B12 blend, IM or SubQ, weekly to twice weekly (proposed — pending dosing review)community
Typical componentsMethionine, inositol, choline (MIC) + B12; sometimes L-carnitine or extra B-vitamins — formulations vary widely between clinicscommunity
Frequency / routeIntramuscular (gluteal/deltoid) or subcutaneous; 1–2×/week is the common clinic cadencecommunity
ContextAlways paired with a calorie-restricted diet and/or coaching — the program, not the shot, is doing the workcommunity
Pushing higher— going beyond the standard dosecommunity
There’s nothing to push toward. Because the fat-loss effect of the injection itself was never demonstrated, escalating the dose or the frequency chases a result the evidence can’t locate at any amount — the same trap as a fragment that didn’t beat placebo, except here there were never the trials to begin with. The only ceiling worth respecting is the boring nutritional one: choline has a tolerable upper intake limit (high doses cause a fishy body odor, sweating, and GI upset), and more methionine is not benign. More of an inert-for-this-purpose blend is still inert, just with more injection-site soreness.

Side effects & cautions

This is the one place Lipo-C scores well: it’s generally benign. The usual complaints are local and mild — injection-site stinging, soreness, redness, occasional warmth or flushing right after the shot (methionine and B12 can sting going in). Some people report a transient energy bump or mild nausea. Megadoses of choline can cause a fishy odor, sweating, and GI upset; B12 is essentially harmless at these amounts. The blunt framing is the same as for any “very safe” compound that doesn’t do its headline job: it’s well tolerated partly because it isn’t doing much. As always in this space the market is unregulated, so formulation and sterility vary by source — and these are injections, where contamination matters.

Stacking

In the clinic it’s almost never sold alone — it’s stacked onto a weight-loss program, increasingly as an add-on alongside a GLP-1 or in a “skinny shot” bundle. Read honestly, that’s the tell: the load-bearing parts of those protocols are the calorie deficit, the coaching, and (where present) the GLP-1, with Lipo-C riding along as the part with a mechanism story but no independent weight effect. There’s no evidence that adding it improves outcomes over the program by itself. If a component is worth running, it’s for a real reason — correcting a documented B12 or choline shortfall — not for fat loss.

Evidence & sources

Be blunt: the fat-loss claim is unsupported. There are no good human trials showing lipotropic MIC injections cause weight loss independent of diet, and the whole-product evidence is essentially marketing plus anecdote. The individual ingredients do have real, well-documented metabolic roles — choline and methionine in hepatic fat export and methylation, inositol in metabolic signaling, B12 as a cofactor — but those roles are about correcting deficiency, not about producing fat loss in a nourished person. The supporting studies below are about the nutrients, not the injection: they establish that the biology is real, not that the shot works.

  • Zarezadeh M et al. (2021)Review
    Inositol supplementation and body mass index: a systematic review and meta-analysis of randomized clinical trials
    Obesity Science & Practice — modest BMI effect, mostly in PCOS/overweight subgroupsDOI 10.1002/osp4.569
  • da Costa K-A et al. (2005)Human study
    Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load
    American Journal of Clinical Nutrition — choline/methionine/homocysteine metabolism in humansPMID 15699233
  • Gallo M et al. (2023)Review
    Choline: an essential nutrient for human health
    Nutrients — review of choline’s roles in liver, membranes, and methylationDOI 10.3390/nu15132900

More in Vitamins & cofactors